X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (42) 42
neurosciences (33) 33
male (28) 28
animals (22) 22
serotonin (21) 21
humans (20) 20
serotonin-1a receptor (18) 18
rats (17) 17
female (15) 15
pharmacology & pharmacy (14) 14
positron-emission-tomography (14) 14
psychiatry (13) 13
serotonin-1a (13) 13
receptor, serotonin, 5-ht1a - metabolism (12) 12
adult (11) 11
brain (11) 11
depression (11) 11
middle aged (10) 10
serotonin-1a receptors (10) 10
rat-brain (9) 9
hippocampus (8) 8
major depression (8) 8
radiology, nuclear medicine & medical imaging (8) 8
serotonin - metabolism (8) 8
5-ht1a receptor (7) 7
anxiety (7) 7
brain - metabolism (7) 7
corticosterone (7) 7
major depressive disorder (7) 7
neurons (7) 7
phenols (7) 7
positron emission tomography (7) 7
positron-emission tomography (7) 7
5-ht1a receptors (6) 6
8-hydroxy-2-tetralin - pharmacology (6) 6
antidepressants (6) 6
dose-response relationship, drug (6) 6
human brain (6) 6
pet (6) 6
receptors, serotonin - metabolism (6) 6
aged (5) 5
binding (5) 5
brain - diagnostic imaging (5) 5
depressive disorder, major - metabolism (5) 5
in-vivo (5) 5
messenger-rna expression (5) 5
mice (5) 5
piperazines - pharmacokinetics (5) 5
rats, sprague-dawley (5) 5
receptor (5) 5
receptor, serotonin, 5-ht1a - physiology (5) 5
reference region (5) 5
serotonin receptor agonists - pharmacology (5) 5
young adult (5) 5
5-ht (4) 4
5-ht1a (4) 4
analysis of variance (4) 4
article (4) 4
behavior (4) 4
depression, mental (4) 4
depressive disorder, major - diagnostic imaging (4) 4
disease models, animal (4) 4
dorsal raphe nucleus (4) 4
electrophysiology (4) 4
fluoxetine (4) 4
hippocampus - metabolism (4) 4
messenger-rna (4) 4
neuroimaging (4) 4
piperazines - metabolism (4) 4
positron-emission tomography - methods (4) 4
prefrontal cortex (4) 4
pyridines - pharmacokinetics (4) 4
rats, wistar (4) 4
receptors, serotonin - drug effects (4) 4
social anxiety disorder (4) 4
tomography (4) 4
1a receptor (3) 3
8-hydroxy-2-tetralin (3) 3
8-oh-dpat (3) 3
alzheimer's disease (3) 3
antidepressant (3) 3
anxieties (3) 3
autoradiography (3) 3
brain research (3) 3
carbon radioisotopes (3) 3
cerebral cortex - metabolism (3) 3
clinical neurology (3) 3
frontal-cortex (3) 3
hippocampus - drug effects (3) 3
hippocampus - physiology (3) 3
in situ hybridization (3) 3
in vitro techniques (3) 3
medial prefrontal cortex (3) 3
medical imaging (3) 3
metabolites (3) 3
nervous system (3) 3
neuroendocrine responses (3) 3
neurons - drug effects (3) 3
original (3) 3
original article (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neuron, ISSN 0896-6273, 2009, Volume 62, Issue 4, pp. 479 - 493
Understanding the physiopathology of affective disorders and their treatment relies on the availability of experimental models that accurately mimic aspects of... 
STEMCELL | HUMDISEASE | MOLNEURO | SEROTONIN-1A RECEPTOR FUNCTION | MESSENGER-RNA | BETA-ARRESTINS | PROTEIN-COUPLED RECEPTORS | ANTIDEPRESSANT TREATMENT | CELL-PROLIFERATION | ADULT MICE | MAJOR DEPRESSION | DENTATE GYRUS | HIPPOCAMPAL NEUROGENESIS | NEUROSCIENCES | Depression - pathology | Microtubule-Associated Proteins - metabolism | Radiation | Arrestins - genetics | GTP-Binding Protein alpha Subunit, Gi2 - metabolism | Male | Hippocampus - drug effects | Antidepressive Agents, Second-Generation - therapeutic use | RNA, Messenger - metabolism | Arrestins - metabolism | Hypothalamus - radiation effects | Corticosterone - toxicity | Depression - drug therapy | GTP-Binding Protein alpha Subunit, Gi2 - genetics | Anxiety - diet therapy | Depression - chemically induced | Reaction Time - drug effects | Exploratory Behavior - drug effects | Neurogenesis - radiation effects | Neurogenesis - drug effects | Bromodeoxyuridine - metabolism | Fluoxetine - therapeutic use | Hypothalamus - drug effects | Disease Models, Animal | Cell Survival - drug effects | Drug Administration Schedule | Gene Expression Regulation - genetics | Mice, Inbred C57BL | Neuropeptides - metabolism | Hippocampus - pathology | Cell Survival - radiation effects | Anxiety - pathology | Feeding Behavior - drug effects | Mice, Knockout | Gene Expression Regulation - drug effects | Animals | Hypothalamus - metabolism | Analysis of Variance | beta-Arrestin 2 | beta-Arrestins | Hippocampus - radiation effects | Gene Expression Regulation - radiation effects | Anxiety - chemically induced | Cell Proliferation - drug effects | Mice | Arrestins - deficiency | Cell Proliferation - radiation effects | Neurosciences | Corticosterone | Neurons | Fluoxetine | Analysis | Depression, Mental | Models | Survival analysis | Genotype & phenotype | Brain research | Antidepressants | Anxieties | Rodents | Behavior | Feeds | Neurogenesis | Index Medicus
Journal Article
NeuroImage, ISSN 1053-8119, 08/2012, Volume 62, Issue 1, pp. 199 - 206
Journal Article
Journal Article
Journal Article
Journal Article
Molecular Psychiatry, ISSN 1359-4184, 01/2013, Volume 18, Issue 1, pp. 93 - 100
Electroconvulsive therapy (ECT) is a potent therapy in severe treatment-refractory depression. Although commonly applied in psychiatric clinical routine since... 
electroconvulsive therapy | positron emission tomography | major depression | antidepressant | [carbonyl-11C]WAY100635 | serotonin-1A receptor | TRYPTOPHAN | TRANSPORTER | PSYCHIATRY | BIOCHEMISTRY & MOLECULAR BIOLOGY | BRAIN GLUCOSE-METABOLISM | RESISTANT DEPRESSION | AUTORECEPTORS | DISORDERS | NEUROSCIENCES | SHOCK | POSITRON-EMISSION-TOMOGRAPHY | 5-HT2 RECEPTORS | [carbonyl-C-11]WAY100635 | AMYGDALA | Serotonin Antagonists - pharmacokinetics | Humans | Middle Aged | Depressive Disorder, Major - therapy | Pyridines - pharmacokinetics | Male | Depressive Disorder, Major - diagnostic imaging | Positron-Emission Tomography - methods | Antidepressive Agents - therapeutic use | Young Adult | Electroconvulsive Therapy - methods | Carbon Isotopes - pharmacokinetics | Antipsychotic Agents - therapeutic use | Protein Binding - drug effects | Brain Mapping | Adult | Female | Piperazines - pharmacokinetics | Receptor, Serotonin, 5-HT1A - metabolism | Protein Binding - physiology | Care and treatment | Receptors | PET imaging | Serotonin | Electrotherapeutics | Properties | Methods | Major depressive disorder | Cerebellum | Cortex (cingulate) | Amygdala | Cortex (occipital) | Radioisotopes | Depression | Serotonin S1 receptors | Emotions | ECS | Antidepressants | Raphe nuclei | Positron emission tomography | Hippocampus | Index Medicus | Original
Journal Article
American Journal of Physiology - Heart and Circulatory Physiology, ISSN 0363-6135, 01/2008, Volume 294, Issue 1, pp. 474 - 480
Journal Article
Psychoneuroendocrinology, ISSN 0306-4530, 2014, Volume 45, pp. 1 - 10
Journal Article
NeuroImage, ISSN 1053-8119, 01/2014, Volume 84, pp. 1094 - 1100
Journal Article
Neuropharmacology, ISSN 0028-3908, 07/2018, Volume 137, pp. 96 - 103
We previously reported that serotonergic transmission is involved in the antidepressant effects of metabotropic glutamate 2/3 (mGlu2/3) receptor antagonists.... 
Antidepressant | Mechanistic target of rapamycin complex-1 | Phosphoinositide-3 kinase | Metabotropic glutamate 2/3 receptor | Ketamine | 5-HT1A receptor | DEPRESSION | BEHAVIOR | SEROTONIN-1A | INVOLVEMENT | RATS | METABOTROPIC GLUTAMATE RECEPTORS | NEUROSCIENCES | LY341495 | NEURONS | PHARMACOLOGY & PHARMACY | PLASTICITY | Index Medicus
Journal Article